Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC1822754904;54905;54906 chr2:178604008;178604007;178604006chr2:179468735;179468734;179468733
N2AB1658649981;49982;49983 chr2:178604008;178604007;178604006chr2:179468735;179468734;179468733
N2A1565947200;47201;47202 chr2:178604008;178604007;178604006chr2:179468735;179468734;179468733
N2B916227709;27710;27711 chr2:178604008;178604007;178604006chr2:179468735;179468734;179468733
Novex-1928728084;28085;28086 chr2:178604008;178604007;178604006chr2:179468735;179468734;179468733
Novex-2935428285;28286;28287 chr2:178604008;178604007;178604006chr2:179468735;179468734;179468733
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: K
  • RefSeq wild type transcript codon: AAA
  • RefSeq wild type template codon: TTT
  • Domain: Fn3-20
  • Domain position: 62
  • Structural Position: 83
  • Q(SASA): 0.7179
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
K/N rs371332455 -0.025 1.0 N 0.745 0.277 0.233785782151 gnomAD-2.1.1 8.04E-06 None None None None N None 0 0 None 0 0 None 0 None 0 1.78E-05 0
K/N rs371332455 -0.025 1.0 N 0.745 0.277 0.233785782151 gnomAD-4.0.0 1.59306E-06 None None None None N None 0 0 None 0 0 None 0 0 2.86239E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
K/A 0.4522 ambiguous 0.3668 ambiguous -0.083 Destabilizing 0.999 D 0.649 neutral None None None None N
K/C 0.7799 likely_pathogenic 0.7268 pathogenic -0.631 Destabilizing 1.0 D 0.711 prob.delet. None None None None N
K/D 0.616 likely_pathogenic 0.5521 ambiguous -0.36 Destabilizing 1.0 D 0.721 prob.delet. None None None None N
K/E 0.3223 likely_benign 0.2577 benign -0.381 Destabilizing 0.999 D 0.583 neutral N 0.487638607 None None N
K/F 0.8938 likely_pathogenic 0.8297 pathogenic -0.482 Destabilizing 1.0 D 0.687 prob.neutral None None None None N
K/G 0.4903 ambiguous 0.4091 ambiguous -0.172 Destabilizing 1.0 D 0.656 neutral None None None None N
K/H 0.3778 ambiguous 0.3149 benign -0.206 Destabilizing 1.0 D 0.671 neutral None None None None N
K/I 0.6278 likely_pathogenic 0.526 ambiguous 0.068 Stabilizing 1.0 D 0.704 prob.neutral N 0.478005057 None None N
K/L 0.5429 ambiguous 0.4465 ambiguous 0.068 Stabilizing 1.0 D 0.656 neutral None None None None N
K/M 0.4582 ambiguous 0.368 ambiguous -0.265 Destabilizing 1.0 D 0.667 neutral None None None None N
K/N 0.5135 ambiguous 0.4496 ambiguous -0.164 Destabilizing 1.0 D 0.745 deleterious N 0.48787068 None None N
K/P 0.5915 likely_pathogenic 0.4904 ambiguous 0.038 Stabilizing 1.0 D 0.706 prob.neutral None None None None N
K/Q 0.1981 likely_benign 0.1558 benign -0.29 Destabilizing 1.0 D 0.727 prob.delet. N 0.497740957 None None N
K/R 0.0959 likely_benign 0.0862 benign -0.202 Destabilizing 0.999 D 0.519 neutral N 0.47628825 None None N
K/S 0.5142 ambiguous 0.4263 ambiguous -0.512 Destabilizing 0.999 D 0.651 neutral None None None None N
K/T 0.3006 likely_benign 0.2353 benign -0.431 Destabilizing 1.0 D 0.713 prob.delet. N 0.476229534 None None N
K/V 0.5477 ambiguous 0.4685 ambiguous 0.038 Stabilizing 1.0 D 0.675 prob.neutral None None None None N
K/W 0.87 likely_pathogenic 0.7883 pathogenic -0.597 Destabilizing 1.0 D 0.713 prob.delet. None None None None N
K/Y 0.7559 likely_pathogenic 0.6759 pathogenic -0.258 Destabilizing 1.0 D 0.661 neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.